inggui Yangyuan Paste for patients with male infertility: a multicenter, double-blind, double-dummy, randomized controlled trial

Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China0 个研究点开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•(1) Study participants met the diagnostic criteria for male infertility
•(2) Study participants met the diagnostic criteria for asthenozoospermia or oligoasthenozoospermia
•(3) Study participants met the traditional Chinese medicine diagnosis criteria for kidney deficiency and blood stasis
•(4) Men aged 22 to 45 years
•(5) The participants signed informed consent forms

•(1)infertility is caused by the inability to complete sexual intercourse, including but not limited to erectile dysfunction or ejaculatory disorders
•(2)with infertility caused by organic lesions of the reproductive system
•(3)with reproductive system infection, such as chlamydia trachomatis or mycoplasma infection
•(4)with palpable varicocele
•(5)with abnormal and clinical significance of sex hormone (follicle stimulating, hormoneluteinizing, testosterone)
•(6)complicated with liver and kidney dysfunction, severe basic diseases such as diabetes, cardiovascular and cerebrovascular diseases, mental diseases, malignant tumors, or serious organic diseases
•(7)with a history of allergy to any medicine or ingredients used in this study
•(8)receive other relevant treatment for the disease 2 weeks before treatment

发起方

Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China